<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">TETRAHYDROZOLINE HYDROCHLORIDE</span><br/>(tet-ra-hye-drozz'a-leen)<br/><span class="topboxtradename">Collyrium, </span><span class="topboxtradename">Mallazine, </span><span class="topboxtradename">Murine Plus, </span><span class="topboxtradename">Optigene, </span><span class="topboxtradename">Soothe, </span><span class="topboxtradename">Tyzine, </span><span class="topboxtradename">Visine<br/></span><b>Classifications:</b> <span class="classification">eye, ear, nose, and throat preparation</span>; <span class="classification">vasoconstrictor</span>; <span class="classification">decongestant</span><br/><b>Prototype: </b>Naphazoline<br/><b>Pregnancy Category: </b>C<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>0.05% ophthalmic solution; 0.05%, 0.1% nasal solution</p>
<h1><a name="action">Actions</a></h1>
<p>Related to naphazoline but shares more marked alpha-adrenergic than beta-adrenergic activity; large doses cause CNS depression
         rather than the stimulation produced by other sympathomimetic amines.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Ophthalmic solution is effective for allergic reactions of the eye; nasal solution is antiinflammatory and also decreases
         allergic congestion.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Symptomatic relief of minor eye irritation and allergies and for nasopharyngeal congestion of allergic or inflammatory origin.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to any component; use of ophthalmic preparation in glaucoma or other serious eye diseases; use within 14
         d of MAO inhibitor therapy. Use in children 
      </p><h1><a name="precaution">Cautious Use</a></h1>
<p>Hypertension; cardiovascular disease; hyperthyroidism; diabetes mellitus; young children; lactation.</p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Decongestant</span><br/><span class="rdage">Adult:</span> <span class="rdroute">Ophthalmic</span> See Appendix A-1. <span class="rdroute">Nasal</span> 24 drops of 0.1% solution or spray in each nostril q3h prn<br/><span class="rdage">Child:</span> <span class="rdroute">Nasal</span> <i>26 y,</i> 24 drops of 0.05% solution or spray in each nostril q3h prn; <img src="../images/special/greaterorequal.gif"/>
<i>6 y,</i> same as adult<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Instillation</span><br/><ul>
<li>Make sure interval between doses is at least 46 h since drug action lasts 48 h.</li>
<li>Place patient in upright position when using nasal spray. (If patient is reclining, a stream rather than a spray may be ejected,
            with consequent overdosage.)
         </li>
<li>Use lateral, head-low position to administer nasal drops.</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">Special Senses:</span> <span class="speceff-common">Transient stinging,</span> irritation, <span class="speceff-common">sneezing,</span> dryness, headache, tremors, drowsiness, light-headedness, insomnia, palpitation. <span class="typehead">Body as a Whole:</span> With overdose: marked drowsiness, sweating, <span class="speceff-life">coma</span>, hypotension, <span class="speceff-life">shock</span>, bradycardia. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> May be absorbed from nasal mucosa. <span class="typehead">Duration:</span> 48 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Discontinue medication and consult physician if relief is not obtained within 48 h or if symptoms persist or increase.</li>
<li>Do not exceed recommended dosage. Rebound congestion and rhinitis may occur with frequent or prolonged use of nasal preparation.</li>
<li>Do not breast feed while using this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>